Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Delayed Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
5.36 USD +1.71% Intraday chart for Vanda Pharmaceuticals Inc. -10.37% +27.01%
Jul. 01 Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz MT
Jul. 01 Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Value-Defensive Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Federal Court Allows Vanda's HETLIOZ Patent Lawsuit to Proceed against Teva and Apotex
AQ
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz
MT
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex
PR
Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Value-Defensive Index
CI
Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Defensive Index
CI
The same old winners
Our Logo
Future Pak withdraws offer to buy Vanda Pharmaceuticals
RE
Future Pak, Ltd. cancelled the acquisition of Vanda Pharmaceuticals Inc. from The Vanguard Group, Inc., Renaissance Technologies LLC, BlackRock, Inc., Butler Hall Capital LLC, Shareholder Capital LLC and others.
CI
Vanda rejects Future Pak and Cycle Pharma's takeover offers
RE
Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders
PR
Cycle Pharmaceuticals Limited cancelled the acquisition of Vanda Pharmaceuticals Inc..
CI
Sector Update: Health Care Stocks Ease Late Afternoon
MT
Sector Update: Health Care Stocks Softer Thursday Afternoon
MT
Sector Update: Health Care
MT
Vanda Pharmaceuticals Receives Revised Offer From Future Pak; Shares Rise
MT
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
PR
Future Pak raises cash portion of buyout offer for Vanda
RE
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
BU
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
MT
Sector Update: Health Care Stocks Advance Thursday Afternoon
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.